Agilent Technologies, Inc. (A) Q3 2024 Earnings Call Transcript
Agilent Technologies, Inc. (NYSE:A ) Q3 2024 Earnings Conference Call August 21, 2024 4:30 PM ET Company Participants Conference Call Participants Operator Ladies and gentlemen, welcome to the Agilent Technologies Q3 2024 Earnings Call. My name is Regina and I will be coordinating your call today.
Agilent (A) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Agilent (A) give a sense of how the business performed in the quarter ended July 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Agilent Technologies (A) Q3 Earnings and Revenues Beat Estimates
Agilent Technologies (A) came out with quarterly earnings of $1.32 per share, beating the Zacks Consensus Estimate of $1.25 per share. This compares to earnings of $1.43 per share a year ago.
Agilent beats quarterly results on strong demand from biotech clients
Agilent Technologies on Wednesday beat Wall Street estimates for third-quarter profit and revenue, banking on strong demand for its medical tools and equipment used in clinical studies.
Agilent (A) Boosts LSAG Segment With J&W 5Q GC/MS Columns
Agilent Technologies (A) launches J&W 5Q GC/MS Columns to address the growing demand for modern laboratories.
Wall Street's Insights Into Key Metrics Ahead of Agilent (A) Q3 Earnings
Beyond analysts' top -and-bottom-line estimates for Agilent (A), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended July 2024.
Analysts Estimate Agilent Technologies (A) to Report a Decline in Earnings: What to Look Out for
Agilent (A) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Agilent (A) Boosts DCG Segment With New ProteoAnalyzer System
Agilent (A) unveils its new ProteoAnalyzer system in a bid to strengthen its Diagnostics and Genomics Group segment.
Agilent to buy contract drug manufacturer Biovectra for $925 million
Agilent Technologies said on Monday it will acquire contract drug manufacturer Biovectra for $925 million to expand its portfolio of services offered to biotech companies and medical researchers.
History Says These Could Be 3 of the Best Healthcare Stocks to Own in the Second Half of 2024
Intuitive Surgical's game-changing robotic surgical systems should continue fueling considerable growth for the business. UnitedHealth is in an excellent position to benefit from the health insurance industry's long-term growth.
Why Is Agilent (A) Down 0.5% Since Last Earnings Report?
Agilent (A) reported earnings 30 days ago. What's next for the stock?
New Strong Sell Stocks for June 7th
A, CAR and BGS have been added to the Zacks Rank #5 (Strong Sell) List on June 7, 2024.
